PAREXEL Closes $750M Unsecured Loan

PAREXEL Closes $750M Unsecured Loan

Firm News

WilmerHale represented PAREXEL International Corporation—a leading global biopharmaceutical services organization—in a $750 million unsecured term loan and revolving credit facility, which closed on March 11, 2016.  The loan facility will be made available to PAREXEL International Corporation as well as its Dutch and Irish subsidiaries.
 
The WilmerHale team for this transaction was led by Partner John Sigel, Special Counsel Jamie Class and Senior Associate Ellie Guadiana.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.